Literature DB >> 27291585

Novel biomarkers of coronary microvascular disease.

Olivia Y Hung1, Suegene K Lee2, Parham Eshtehardi1, Habib Samady1.   

Abstract

Coronary microvascular disease in the absence of myocardial diseases has traditionally been diagnosed through coronary reactivity testing in the cardiac catheterization laboratory. Compared with invasive procedures, blood-based biomarkers may have reduced cost, less risk of physical harm and greater accessibility, making them ideal for an outpatient management strategy. There are a variety of biomarkers available with potential utility in the management of microvascular disease; however, none have yet been extensively validated or established in this clinical patient population.

Entities:  

Keywords:  biomarkers; coronary flow reserve; coronary microvascular disease

Mesh：

Substances：

Year:  2016        PMID： 27291585      PMCID： PMC5941701          DOI： 10.2217/fca-2016-0012

Source DB:  PubMed          Journal:  Future Cardiol        ISSN： 1479-6678


  84 in total

1.  Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease.

Authors:  Jaskanwal D Sara; R Jay Widmer; Yasushi Matsuzawa; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  JACC Cardiovasc Interv       Date:  2015-09       Impact factor: 11.195

2.  Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation.

Authors:  H G Bohlen; X Zhou; J L Unthank; S J Miller; R Bills
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

Review 3.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

4.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

5.  Circulating N-terminal brain natriuretic peptide precursor and endothelin levels in patients with syndrome X and left bundle branch block with preserved systolic function.

Authors:  D Dudek; L Rzeszutko; P Petkow Dimitrow; S Bartus; D Sorysz; M Chyrchel; T Rakowski; A Zdzienicka; I Guevara; A Dembinska-Kiec; J S Dubiel
Journal:  Int J Cardiol       Date:  2001-06       Impact factor: 4.164

6.  The effects of dipyridamole stress test on plasma levels of soluble adhesion molecules intracellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin and L-selectin in patients with ischemic heart disease and patients with syndrome X.

Authors:  T Siminiak; J Smielecki; J Rzeźniczak; M Kaźmierczak; R Kalawski; H Wysocki
Journal:  Coron Artery Dis       Date:  1999-06       Impact factor: 1.439

7.  Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms.

Authors:  E Hoffmann; P Assennato; M Donatelli; I Colletti; T M Valenti
Journal:  Am Heart J       Date:  1998-04       Impact factor: 4.749

8.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

Review 9.  Role of endothelium in ischemic coronary syndromes.

Authors:  I T Meredith; T J Anderson; A Uehata; A C Yeung; A P Selwyn; P Ganz
Journal:  Am J Cardiol       Date:  1993-09-09       Impact factor: 2.778

10.  Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

Authors:  Jaw-Wen Chen; Nai-Wei Hsu; Tao-Cheng Wu; Shing-Jong Lin; Mau-Song Chang
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778
View more
  5 in total

Review 1.  Common Shared Pathogenic Aspects of Small Vessels in Heart and Brain Disease.

Authors:  Rita Moretti; Milijana Janjusevic; Alessandra Lucia Fluca; Riccardo Saro; Giulia Gagno; Alessandro Pierri; Laura Padoan; Luca Restivo; Agnese Derin; Antonio Paolo Beltrami; Paola Caruso; Gianfranco Sinagra; Aneta Aleksova
Journal:  Biomedicines       Date:  2022-04-27

2.  Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.

Authors:  Basmah Safdar; Xiaojia Guo; Caitlin Johnson; Gail D'Onofrio; James Dziura; Albert J Sinusas; Jeffrey Testani; Veena Rao; Gary Desir
Journal:  Int J Cardiol       Date:  2019-01-02       Impact factor: 4.164

3.  The association of 18F-FDG PET/CT and biomarkers in confirming coronary microvascular dysfunction.

Authors:  Henry Anselmo Mayala; Khamis Hassan Bakari; Abdalah Mkangala; Mafuru Magesa; Fabian Pius Mghanga; Wang ZhaoHui
Journal:  BMC Res Notes       Date:  2018-11-06

Review 4.  Sex-Specific Aspects in the Pathophysiology and Imaging of Coronary Macro- and Microvascular Disease.

Authors:  Floor Groepenhoff; Sophie H Bots; Elise L Kessler; Ariane A Sickinghe; Anouk L M Eikendal; Tim Leiner; Hester M den Ruijter
Journal:  J Cardiovasc Transl Res       Date:  2019-08-30       Impact factor: 4.132

5.  Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease.

Authors:  Ahmed Al-Badri; Ayman Samman Tahhan; Nabil Sabbak; Ayman Alkhoder; Chang Liu; Yi-An Ko; Viola Vaccarino; Afif Martini; Arianna Sidoti; Cydney Goodwin; Bahjat Ghazzal; Agim Beshiri; Gillian Murtagh; Puja K Mehta; Arshed A Quyyumi
Journal:  J Am Heart Assoc       Date:  2020-04-17       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.